Canada: Competition Bureau Releases Draft Updated Intellectual Property Enforcement Guidelines

On April 2, 2014, the Competition Bureau (Bureau) released draft updated Intellectual Property Enforcement Guidelines (Revised IPEGs) for a 60-day consultation period. The Revised IPEGs principally reflect the amendments to the Competition Act (Act) that have been made since the IPEGs were released in 2000 (2000 IPEGs). With one exception, the Revised IPEGs maintain the same conceptual approach as the 2000 IPEGs regarding the interface between competition policy and intellectual property (IP) rights. However, the Revised IPEGs do not deal with some of the more recent challenges – most notably the application of competition law to pharmaceutical patent settlements, which have received extensive attention from the U.S. Federal Trade Commission in recent years and were the subject of a landmark decision of the U.S. Supreme Court in 2013.1 In this regard, the Bureau appears not to have closed the door on its willingness to elaborate on these thorny issues and, in fact, has invited commentators to "indicate if there are other competition/IP issues that they believe the Bureau should address"2 as part of the consultation process.

Competition Bureau's Overall Approach

Consistent with the 2000 IPEGs, the Bureau's approach to the IP-competition interface is "based on the premise that the Act generally applies to conduct involving IP as it applies to conduct involving other forms of property."3 Also consistent with the 2000 IPEGs, the foundation of the Bureau's enforcement approach is the determination of whether the conduct, transaction or arrangement in question involves either

  • the mere exercise of the IP right and nothing else (e.g., the exercise of the owner's right to unilaterally exclude others from using the IP) to which the rarely used section 32 (special remedies) of the Act applies; or
  • something more than the mere exercise of the IP right (e.g., the licence, transfer or sale of IP to a firm or group of firms that would have been actual or potential competitors without the arrangement) to which the general provisions of the Act apply (e.g., section 90.1– civil agreements between competitors; section 79 – abuse of dominance).

The Revised IPEGs explain that when conduct or an arrangement is something more than the mere exercise of the IP right and that arrangement "creates, enhances or maintains market power, the Bureau may seek to challenge the arrangement under the appropriate section of the Act."4

This distinction between "mere exercise" and "something more than mere exercise" is critical. In this respect the Revised IPEGs reflect a change in the Bureau's interpretation of a "mere exercise" of the IP right. In the 2000 IPEGs, the Bureau identified an IP owner's use or non-use of the IP as being the mere exercise of an IP right.5 Significantly, in the Revised IPEGs, the Bureau has indicated that it will analyze an IP owner's non-use of IP under the general provisions of the Act, meaning that the Bureau considers the non-use of IP as something more than the mere exercise of an IP right.

The Bureau has suggested that product hopping (which involves an originator's substituting an older product whose patent is about to expire with a newer innovation to avoid generic competition with the older product) is an example of an IP owner's non-use of IP possibly raising concerns under the Act. In this regard, the Bureau is investigating Alcon under the abuse of dominance provisions of the Act.6

Section 32 and "Mere Exercise"

Section 32 of the Act contemplates a special remedy that endows the Federal Court with broad powers to prevent the use of IP rights to unduly restrain trade or lessen competition. In contrast with the general remedial provisions of the Act, even the mere exercise of an IP right may attract scrutiny under section 32. Although the Federal Court's remedial powers under section 32 are quite broad,7 only the Attorney General of Canada may initiate a proceeding.

The special remedy provisions were originally enacted in 1910, but proceedings have only been initiated under section 32 on two occasions in well over 100 years and both resulted in settlements prior to a judicial determination. In the absence of judicial clarification of the application of section 32, the Commissioner of Competition's enforcement position with regard to section 32 is highly relevant.

The discussion of section 32 in the Revised IPEGs is virtually identical to that contained in the 2000 IPEGs. The Bureau expects recourse to section 32 to be necessary "only in certain narrowly defined circumstances,"8 and identifies three factors that must each be satisfied for the Bureau to even recommend an application under section 32: (i) the IP holder must be dominant in the relevant market; (ii) the IP must be an essential input or resource for firms participating in the relevant market; and (iii) if the first two factors are satisfied, the Bureau must agree that invoking a special remedy would not adversely alter the incentives to invest in research and development in the economy (this is satisfied if the refusal to license the IP is stifling further innovation and not simply preventing the replication of existing products).

The Act's Application to "Something More"

The Revised IPEGs do not reflect any changes from the 2000 IPEGs' framework for analyzing conduct, transactions and arrangements under the Act's general provisions, other than making clear that arrangements between competitors involving IP (e.g., IP licensing arrangements) may be analyzed under section 90.1 in addition to the other general provisions of the Act, and removing references to "unduly" as they related to the former section 45.

While the Bureau reiterates its general view that "market conditions and the differential advantages IP provides should largely determine commercial rewards flowing from the exploitation of an IP right in the market to which it relates,"9 the Bureau may intervene in a use of IP rights to create, enhance or maintain market power. Unfortunately, subject to some minor modifications, the Revised IPEGs simply repeat (in the text and the hypotheticals) the same examples (with one deletion)10 that are in the 2000 IPEGs of conduct involving something more than the mere exercise of an IP right that the Bureau may challenge.

It is worth noting that unlike the 2000 IPEGs, which stated that disputes concerning illegitimate extensions of an IP right "are best resolved by"11 IP authorities, the Revised IPEGs state that the Bureau "will use its enforcement discretion and may choose to leave the matter to be resolved by the appropriate IP authority under the appropriate IP statute."12 In this regard, on the same day the Bureau released the Revised IPEGs, it announced that it had signed a Memorandum of Understanding (MOU) with the Canadian Intellectual Property Office (CIPO).13 The MOU provides for collaboration between the Bureau and CIPO on policies that may affect each other's mandates, in addition to referrals from CIPO to the Bureau concerning competition law concerns arising from IP rights. The Bureau and CIPO have also agreed to participate in "knowledge transfer sessions" and collaborative discussions on areas of mutual interest, in addition to various types of information sharing.

More Guidance

Since 2013, the Bureau has demonstrated a renewed willingness to discuss the complex issues in the IP-competition law interface. For example, in November 2013, the Bureau hosted a workshop on the competition issues in the pharmaceutical sector, which included sessions involving the Bureau, the bar, the United States Federal Trade Commission, Industry Canada, the PMPRB, Health Canada and the industry on international perspectives on competition policy in pharmaceuticals, patent settlements and pharmaceutical life-cycle management.

While it is reassuring that the Revised IPEGs do not represent a departure from the Bureau's enforcement position as set out in the 2000 IPEGs, the Bureau should seize the opportunity to clarify in the Revised IPEGs its view on the application of the Act to recent matters that businesses and the Bureau are discussing.

In light of long-standing public and controversial debate in the United States on competition law implications of patent settlements14 and the significant increase of competition-based private actions (class or individual) in Canada, the Bureau's current silence on this particular issue is almost deafening.

Footnotes

1. Federal Trade Commission v. Actavis, Inc., 570 U.S. ___ (June 17, 2013) (slip op.). See Osler Update here.

2. Competition Bureau, "Competition Bureau Seeks Input on the Updated Intellectual Property Enforcement Guidelines," online: Competition Bureau.

3. Revised IPEGs, section 1.

4. Revised IPEGs, section 4.2.1.

5. 2000 IPEGs, section 4.2.1.

6. The Commissioner is investigating whether Alcon intentionally disrupted the supply of Patanol in July 2012, prior to the commencement of generic supply of the product, to habituate physicians into prescribing its much newer Pataday product. The Bureau has sought an order under section 11 of the Act compelling Alcon to produce internal documents pertaining to the investigation, which remains ongoing (Federal Court File No. T-2223-12).

7. The Federal Court's powers include declaring void any agreement, arrangement or licence relating to use of an IP right; restraining any person from exercising any term or provision of any agreement, arrangement or licence; directing the grant of licences to such persons as the Court may deem proper or revoking a patent; directing that the registration of a trade-mark be expunged or amended; and any other acts that the Court may deem necessary to prevent such use.

8. Revised IPEGs, section 4.2.2.

9. Revised IPEGs, section 4.2.1.

10. The only material change is the deletion of the hypothetical application of the conspiracy (section 45) and joint abuse of dominance provisions to joint foreclosure by a group of licensors through exclusive licensing arrangements with a dominant licensee.

11. 2000 IPEGs, section 4.2.3.

12. Revised IPEGs, section 4.2.3.

13. Competition Bureau, "Memorandum of Understanding between the Commissioner of Patents, Registrar of Trade-marks and Chief Executive Officer of the Canadian Intellectual Property Office and the Commissioner of Competition of the Competition Bureau," online: Competition Bureau.

14. See Osler Update here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions